维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="SCHWARZ UI"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Genetic determinants of response towarfarin during initial anticoagulation显示文摘	Schwarz UI Ritchie MD Bradford Y	2008	N Engl J Med2008，358，：	1
2	Genetic determi- nants of response to warfarin during initial anticoagulation显示文摘	Schwarz UI Ritchie MD Yuki Bradford	2008	N Engl J Med2008，358，10：	1
3	P glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans 显示文摘	Schwarz UI Gramatte T rappweis JK	2000	In J Clin Pharm and Ther2000，38，4：	1
4	Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy显示文摘	GONG IY TIRONA RG SCHWARZ UI	2011	Blood2011，118，11：	1
5	Unwanted pregnancy on self-medication with St John's Wort despite hormonal contra- ception 显示文摘	Schwarz UI Biaschel B Kirch W	2003	Br J Clin Pharmacol2003，55，1：	1
6	Genetic deter- minants of response to warfarin during initial anticoagulation 显示文摘	Schwarz UI Ritchie MD Bradford Y	2008	N Engl J Med2008，358，：	1
7	Grapefruit juice ingestion significantly reduces talinolol bioavailability 显示文摘	Schwarz UI Seemann D Oertel B	2005	Clin Pharmacol Ther2005，77，4：	1
8	Identification of novel functional organic anion-transporting polypeptide lb3 polymorphisms and assessment of substrate specificity 显示文摘	Schwarz UI Meyer zu Schwabedissen HE Tirona RG	2011	Pharmacogenet Genomics2011，21，3：	1
9	Cytochrome P4502D6phenotyping in an elderly population with de-mentia and response to galantamine in dementia:a pilot study显示文摘	Clarke JA Cutler M Gong I Schwarz UI Freeman D Dasgupta M	2011	Am J Geriatr Pharmacother2011，9，4：	1
10	P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans显示文摘	SCHWARZ UI GRAMATT T KRAPPWEIS J	2000	Clin Pharmacol Ther2000，38，4：	1
11	Clinical relevance of genetic polymorphisms in the human CYP2C9 gene 显示文摘		2003	Eur J Clin Invest2003，33，2：	1
12	P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans显示文摘	Schwarz UI Gramatte T Krappweis J	2000	Int J Clin Pharmacol Ther2000，38，：	1
13	Grapefruit juice ingestion significantly reduces talinolol bioavailability显示文摘	Schwarz UI Seemann D Oertel R	2005	Clin Pharmacol Ther2005，77，：	1
14	Clinical and ge- netic determinants of warfarin pharmacokinetics and phar- macodynamics during treatment initiation 显示文摘	Gong IY Schwarz UI Crown N	2011	PlosOne2011，6，27：	1
15	Clinical and Pharmac- ogenetic Predictors of Circulating Atorvastatin and Rosuvasta tinConcentration in Routine Clinical Care显示文摘	Degorter MK Tirona RG Schwarz UI	2013	Circ Cardiovasc Genet2013，6，4：	1
16	Prospective e- valuation of a pharmacogenetics-guided warfarin load- ing and maintenance dose regimen for initiation of therapy显示文摘	Gong IY Tirona RG Schwarz UI	2011	Blood2011，118，11：	1
17	Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants显示文摘	Schwarz UI Stein CM	2006	Clin Pharmacol Ther2006，80，1：	1
18	P-glycopro- tein inhibitor erythromycin increases oral bioavailability of talinolol in humans显示文摘	Schwarz UI Gramatte T Krappweis J	2000	Int J Clin Pharmacolther2000，38，4：	1
19	Clinical relevance of genetic polymorphisms in thehuman CYP2C9 gene显示文摘	Schwarz UI	2003	Eur J Clin Invest2003，33，12：	1
20	Clinical relevance of genetic polymorphisms in the human CYP2C9 gene 显示文摘	Schwarz UI	2003	Eur J Clin Invest2003，33，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示